OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CCO58

Cameco Corp

UraniumVerified

Cameco Corp's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.42, suggesting it can cover short-term obligations but with limited surplus. Free cash flow is negative at -3.91 million CAD, and operating cash flow is 63.16 million CAD, highlighting a mismatch between operating performance and capital outflows. Profitability metrics show a return on equity of -0.12% and a return on assets of -0.07%, both below the industry median for uranium producers. The company reported a net loss of 7.06 million CAD, despite a gross profit of 186.82 million CAD, indicating high operating expenses or non-operating charges. The operating margin is 20.01%, which is in line with the industry average but does not fully offset the net loss. Cameco Corp's revenue is concentrated in the uranium segment, with no disclosed geographic diversification in the latest financials. The company operates in a single business line, which increases exposure to commodity price volatility and regulatory shifts in the nuclear energy sector. The company's growth trajectory is mixed. Revenue for the latest period was 633.55 million CAD, but no year-over-year growth rate is provided. Analysts have assigned a mean price target of 175.98 CAD, with a median of 178.01 CAD, suggesting moderate upside potential. However, the net loss and negative free cash flow raise concerns about the sustainability of growth without external financing. Risk factors include liquidity constraints, as net cash is negative after subtracting total debt. The company has a low dilution risk, with no near-term pressure from share issuance. However, the negative free cash flow and capital expenditures of -40.02 million CAD suggest potential future dilution if financing is required to fund operations or expansion. Recent events include a net loss and a negative free cash flow, which may signal operational challenges or strategic investments. No recent filings or transcripts are provided in the input data to further contextualize these results.

30-day price · CCO+0.02 (+0.8%)
Low$2.38High$2.42Close$2.40As of8 Jun, 00:00 UTC
Profile
CompanyCameco Corp
TickerCCO.TO
SectorEnergy
BusinessUranium
Industry groupUranium
IndustryUranium
AI analysis

Business. Cameco Corp is a uranium mining and production company that generates revenue primarily through the extraction, processing, and sale of uranium concentrates and uranium hexafluoride.

Classification. Cameco Corp is classified under the Energy economic sector, Uranium business sector, and Uranium industry with a confidence level of 0.92.

Cameco Corp's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.42, suggesting it can cover short-term obligations but with limited surplus. Free cash flow is negative at -3.91 million CAD, and operating cash flow is 63.16 million CAD, highlighting a mismatch between operating performance and capital outflows. Profitability metrics show a return on equity of -0.12% and a return on assets of -0.07%, both below the industry median for uranium producers. The company reported a net loss of 7.06 million CAD, despite a gross profit of 186.82 million CAD, indicating high operating expenses or non-operating charges. The operating margin is 20.01%, which is in line with the industry average but does not fully offset the net loss. Cameco Corp's revenue is concentrated in the uranium segment, with no disclosed geographic diversification in the latest financials. The company operates in a single business line, which increases exposure to commodity price volatility and regulatory shifts in the nuclear energy sector. The company's growth trajectory is mixed. Revenue for the latest period was 633.55 million CAD, but no year-over-year growth rate is provided. Analysts have assigned a mean price target of 175.98 CAD, with a median of 178.01 CAD, suggesting moderate upside potential. However, the net loss and negative free cash flow raise concerns about the sustainability of growth without external financing. Risk factors include liquidity constraints, as net cash is negative after subtracting total debt. The company has a low dilution risk, with no near-term pressure from share issuance. However, the negative free cash flow and capital expenditures of -40.02 million CAD suggest potential future dilution if financing is required to fund operations or expansion. Recent events include a net loss and a negative free cash flow, which may signal operational challenges or strategic investments. No recent filings or transcripts are provided in the input data to further contextualize these results.
Key takeaways
  • Cameco Corp has a conservative debt-to-equity ratio of 0.25, but its free cash flow is negative, indicating potential liquidity constraints.
  • The company reported a net loss of 7.06 million CAD despite a gross profit of 186.82 million CAD, suggesting high operating expenses or non-operating charges.
  • Analysts have a generally positive outlook, with a mean price target of 175.98 CAD and a median of 178.01 CAD.
  • Revenue is concentrated in the uranium segment, with no geographic diversification disclosed, increasing exposure to commodity price volatility.
  • The company faces liquidity risk due to negative net cash after subtracting total debt, but dilution risk is currently low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue$633.5M
Gross profit$186.8M
Operating income$126.7M
Net income-$7.1M
R&D
SG&A
D&A
SBC
Operating cash flow$63.2M
CapEx-$40.0M
Free cash flow-$3.9M
Total assets$9.50B
Total liabilities$3.39B
Total equity$6.11B
Cash & equivalents$88.8M
Long-term debt$1.53B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.47B-$115.0M-$102.6M-$25.3M
FY-3$1.87B$37.9M$89.4M$141.6M
FY-2$2.59B$282.9M$360.8M$410.6M
FY-1$3.14B$510.1M$171.9M$171.4M
FY0$3.48B$618.1M$589.6M$453.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$7.52B$4.85B$642.9M
FY-3$8.63B$5.84B$441.9M
FY-2$9.93B$6.09B$337.1M
FY-1$9.91B$6.36B$395.7M
FY0$10.30B$6.90B$309.0M
PeriodOCFCapExFCFSBC
FY-4$458.3M-$98.8M-$25.3M
FY-3$304.6M-$143.4M$141.6M
FY-2$688.1M-$153.6M$410.6M
FY-1$905.3M-$211.6M$171.4M
FY0$1.41B-$333.0M$453.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$633.5M$126.7M-$7.1M-$3.9M
FQ-6$598.5M$102.0M$36.0M$51.0M
FQ-5$720.6M$100.3M$7.4M$18.2M
FQ-4$1.18B$181.0M$135.5M$175.8M
FQ-3$789.4M$185.8M$69.8M$73.9M
FQ-2$877.0M$166.0M$320.9M$332.4M
FQ-1$614.6M$93.0M-$141.0k-$33.6M
FQ0$1.20B$173.3M$199.1M$184.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$9.50B$6.11B$88.8M
FQ-6$9.38B$6.19B$129.0M
FQ-5$9.29B$6.21B$0.00
FQ-4$9.91B$6.36B$395.7M
FQ-3$9.38B$6.49B$95.0M
FQ-2$9.58B$6.74B$263.8M
FQ-1$9.74B$6.78B$229.9M
FQ0$10.30B$6.90B$309.0M
PeriodOCFCapExFCFSBC
FQ-7$63.2M-$40.0M-$3.9M
FQ-6$323.2M-$86.9M$51.0M
FQ-5$375.6M-$147.2M$18.2M
FQ-4$905.3M-$211.6M$175.8M
FQ-3$110.2M-$56.5M$73.9M
FQ-2$575.4M-$131.4M$332.4M
FQ-1$731.1M-$223.9M-$33.6M
FQ0$1.41B-$333.0M$184.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.11B
Net cash-$1.44B
Current ratio1.4
Debt/Equity0.2
ROA-0.1%
ROE-0.1%
Cash conversion-8.9%
CapEx/Revenue-6.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Uranium · cohort 14 companies
MetricCCOActivity
Op margin20.0%-395.2% medp25 -1558.7% · p75 -29.8%top quartile
Net margin-1.1%-371.3% medp25 -1590.3% · p75 -34.4%top quartile
Gross margin29.5%-7.9% medp25 -85.3% · p75 1.0%top quartile
R&D / revenue3.8% medp25 3.8% · p75 3.8%
CapEx / revenue-6.3%-29.6% medp25 -532.5% · p75 -10.0%top quartile
Debt / equity25.0%0.2% medp25 0.0% · p75 7.1%top quartile
Observations
IR observations
Mean price target175.98 CAD
Median price target178.01 CAD
High price target217.18 CAD
Low price target143.22 CAD
Mean recommendation2.14 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count17.00
Hold count2.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate1.57 CAD
Last actual EPS1.44 CAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 05:11 UTC#509cbacd
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 14:53 UTCJob: d0b63802